Drug Regulatory Affairs: FDA, EMA, eCTD & Global Compliance

Name: Drug Regulatory Affairs: FDA, EMA, eCTD & Global Compliance
Rating: 3.9 (30 reviews)

Master the field of global regulatory affairs, compliance, guidelines, submissions and audit readiness tools

Created byDr. Amogh G Nair

Last updated 8/2025

English

What you'll learn

Enhance career prospects in the pharmaceutical industry by mastering regulatory compliance and cross-functional collaboration.
Master the essentials of Drug Regulatory Affairs, including USFDA, EMA, and ICH guidelines for drug development, compliance, and market approval.
Develop strategic regulatory plans and risk management strategies to support pharmaceutical product lifecycles.
Navigate key regulatory processes like CTD/eCTD, IND, NDA, ANDA, and BLA for efficient dossier preparation and submission.
Apply GMP, GCP, and pharmacovigilance principles to ensure manufacturing, clinical, and post-marketing compliance.
Prepare confidently for regulatory affairs certification exams with practical insights into submissions, inspections, and authority interactions.

Course content

5 sections • 20 lectures • 2h 23m total length

Lecture 1.1: Regulatory Affairs Fundamentals8:20
Learning Objective: Define Regulatory Affairs (RA) and its critical role in ensuring drug safety, efficacy, and compliance across the pharmaceutical lifecycle.
Description: Learn the definition, scope, and frameworks of RA, including key terminologies (DRA, regulatory strategy) and their impact on public health. Understand how RA governs drug development from preclinical to post-marketing stages.
Key Takeaways: Master RA’s purpose, scope, and terminology to build a strong foundation for navigating pharmaceutical regulations.
Outcome: Students will be able to define RA and explain its role in ensuring compliance and protecting public health.
Lecture 1.2: Regulatory Affairs (RA) Professionals in Drug Development5:38
Learning Objective: Explain the role of RA professionals in facilitating drug development, market approval, and regulatory compliance through cross-functional collaboration.
Description: Explore how RA professionals bridge pharmaceutical companies and authorities, managing submissions and ensuring compliance for successful market entry. Learn about their responsibilities in regulatory communication and dossier preparation.
Key Takeaways: Understand RA’s pivotal role in achieving market approval through effective compliance and collaboration.
Outcome: Students will be able to describe RA professionals’ responsibilities and their impact on drug development success.
Lecture 1.3: Global Drug Regulatory Authorities6:02
Learning Objective: Identify major regulatory authorities (USFDA, EMA, CD SCO, MHRA, TGA) and their roles in global drug regulation and harmonization.
Description: Discover the jurisdictions and functions of key regulatory bodies, emphasizing the USFDA and global collaboration via ICH. Learn how to navigate agency-specific guidelines for compliance.
Key Takeaways: Gain insights into global regulatory frameworks and their impact on drug development and market access.
Outcome: Students will be able to identify key authorities and explain their roles in pharmaceutical regulation.
Lecture 1.4: Essential Qualities for Regulatory Affairs Success7:43
Learning Objective: Outline essential skills and career opportunities for RA professionals to excel in the pharmaceutical industry.
Description: Learn the critical skills (communication, analytical, strategic thinking) and career paths (associate, consultant, executive) in RA across pharma, CROs, and consultancies. Explore how certifications enhance prospects.
Key Takeaways: Identify skills and career opportunities to succeed in RA and prepare for certification.
Outcome: Students will be able to assess RA career paths and skills needed for professional success.

Lecture 2.1: Regulatory Environment Assessment8:34
Learning Objective: Evaluate the regulatory environment across the product lifecycle to ensure compliance and strategic alignment.
Description: Learn to assess stage-specific regulatory requirements, monitor changes, and maintain documentation for compliance with USFDA and ICH guidelines. Understand how strategic compliance enhances market access.
Key Takeaways: Master systematic evaluation of regulatory environments for lifecycle compliance and competitive advantage.
Outcome: Students will be able to analyze regulatory requirements to ensure product life cycle compliance.
Lecture 2.2: Benefit-Risk Analysis Fundamentals7:08
Learning Objective: Learn risk/benefit analyses using structured frameworks to guide regulatory classification and development strategies.
Description: Explore frameworks like FDA’s BRF and EMA’s PrOACT-URL to assess product viability and regulatory classification (newdrug vs. generic). Learn to evaluate evidence and uncertainties throughout the lifecycle.
Key Takeaways: Apply risk/benefit analysis to optimize regulatory strategies and decision-making.
Outcome: Students will be able to understand risk/benefit analyses to support regulatory classifications.
Lecture 2.3: Global Regulatory Submission Formats (CTDs)7:53
Learning Objective: Develop global regulatory strategies, focusing on CTD and paper submissions for efficient market entry.
Description: Master harmonized dossier preparation, market prioritization, and quality control for eCTD and paper submissions. Learn to adapt strategies for simultaneous filings and evolving requirements.
Key Takeaways: Create standardized dossiers and manage diverse submission formats for global compliance.
Outcome: Students will be able to design global submission strategies to optimize market access.
Lecture 2.4: Mastering Regulatory Intelligence for FDA Engagement11:35
Learning Objective: Gather regulatory intelligence and prepare for effective FDA interactions to advance product development.
Description: Learn to collect intelligence from primary sources, analyze competitor decisions, and prepare for FDA meetings with comprehensive documentation. Understand the importance of ongoing regulatory monitoring.
Key Takeaways: Leveraging regulatory and compliance.
Outcome: Students will be able to apply regulatory intelligence to optimize FDA interactions.

Lecture 3.1: Manufacturing Compliance Foundations (cGMP)5:59
Learning Objective: Apply GMP/cGMP standards to ensure manufacturing compliance for clinical trial materials.
Description: Learn phase-appropriate GMP/cGMP implementation, API/excipient 3 testing, and stability data requirements for IND/CTA compliance. Understand quality assurance processes for clinical trials.
Key Takeaways: Ensure manufacturing compliance through GMP/cGMP and quality documentation.
Outcome: Students will be able to implement GMP/cGMP for clinical trial material compliance.
Lecture 3.2: Nonclinical Testing Framework (GLP, Tox, ICH Guidelines)7:03
Learning Objective: Conduct nonclinical testing under GLP and ICH guidelines to support safe clinical trial initiation.
Description: Explore toxicology, pharmacology, and GLP standards to generate compliant nonclinical data. Learn timing requirements for studies to support clinical phases and marketing authorization.
Key Takeaways: Master nonclinical testing to ensure human safety and regulatory compliance.
Outcome: Students will be able to evaluate nonclinical data for clinical trial authorization.
Lecture 3.3: Clinical Trial Regulatory Framework (GCP Standards, ICH Guidelines)7:09
Learning Objective: Apply ICH and GCP regulations to ensure ethical and compliant clinical trial conduct.
Description: Understand sponsor/investigator responsibilities, informed consent, safety reporting, and documentation for GCP compliance. Learn to uphold ethical principles in clinical research.
Key Takeaways: Ensure ethical trial conduct and data integrity through GCP compliance.
Outcome: Students will be able to implement GCP standards for ethical clinical trials.
Lecture 3.4: Regulatory Submission Types (IND, NDA, ANDA, BLA and ESGs)7:13
Learning Objective: Prepare IND, NDA, ANDA, BLA, and CTD/eCTD submissions for efficient regulatory approval.
Description: Learn the purposes and structures of IND, NDA, ANDA, BLA, and CTD/eCTD. Master dossier preparation and ESG submission processes using tools.
Key Takeaways: Navigate submission processes to streamline drug approval.
Outcome: Students will be able to prepare compliant regulatory submissions for market approval.

Lecture 4.1: Regulatory Compliance in Pharmaceutical Advertising6:30
Learning Objective: Evaluate advertising and labeling for compliance with regulatory requirements.
Description: Learn to create truthful, balanced labeling and promotional materials per USFDA 21CFR Part 202.1. Understand review processes to avoid misleading claims and ensure compliance.
Key Takeaways: Master compliant labeling and advertising for public health protection.
Outcome: Students will be able to evaluate promotional materials for regulatory compliance.
Lecture 4.2: Post-Marketing Change Management6:53
Learning Objective: Managing notifiable changes and adverse event reporting to maintain post-marketing compliance.
Description: Explore change control, supplemental dossiers, and adverse event reporting protocols. Learn to ensure timely and compliant submissions to authorities.
Key Takeaways: Implement robust processes for post-marketing changes and reporting.
Outcome: Students will be able to manage notifiable changes and adverse events effectively.
Lecture 4.3: Risk Management in Pharmaceuticals : A Systematic Approach (DHCPs)6:50
Learning Objective: Develop risk management strategies for recalls, warnings, and healthcare communications.
Description: Learn to assess risks, classify recalls, and issue Dear Healthcare Provider letters per FDA guidelines.
Key Takeaways: Master systematic risk management to protect public health.
Outcome: Students will be able to implement recall and risk communication strategies.
Lecture 4.4: Quality Systems and Lot Distribution (ISO, GxP and CAPA)6:57
Learning Objective: Oversee quality systems and lot distribution to ensure post-marketing compliance with ISO and GxP standards.
Description: Learn to implement independent quality assurance, traceability systems, and recall procedures. Understand ISO and GxP requirements for post-marketing compliance.
Key Takeaways: Ensure product safety through integrated quality systems.
Outcome: Students will be able to oversee compliant quality systems and lot distribution.

Lecture 5.1: Regulatory Inspection Readiness7:26
Learning Objective: Prepare for regulatory inspections and audits to ensure compliance and effective responses.
Description: Learned to establish documentation procedures, train personnel, and conduct internal audits for inspection readiness.
Key Takeaways: Master inspection preparation for regulatory compliance.
Outcome: Students will be able to prepare organizations for successful regulatory inspections.
Lecture 5.2: FDA Briefing Documents5:30
Learning Objective: Coordinate FDA briefing documents to facilitate compliant and strategic regulatory interactions.
Description: Learn to define meeting objectives, structure briefing documents, and present data logically for FDA advisory committee meetings. Ensure cross-functional collaboration for accuracy.
Key Takeaways: Create effective briefing documents for FDA interactions.
Outcome: Students will be able to coordinate compliant FDA briefing documents.
Lecture 5.3: Regulatory Legislation Advisory (BIA, HTA, B-RA)7:39
Learning Objective: Advise on legislation and standards to support compliance and strategic planning.
Description: Learn to monitor regulatory changes, assess legislative impacts, and train stakeholders. Understand how to integrate regulatory intelligence into strategic planning.
Key Takeaways: Provide proactive regulatory advice for compliance and planning.
Outcome: Students will be able to advise on legislation to ensure organizational compliance.
Lecture 5.4: Effective Cross-Functional Collaboration5:40
Learning Objective: Collaborate with CMC, Quality, and Clinical teams to provide regulatory expertise for product development.
Description: Learn to integrate regulatory requirements across functions, coordinate documentation, and ensure consistent dossier messaging. Understand RA’s role in optimizing product claims.
Key Takeaways: Facilitate cross-functional collaboration for regulatory success.
Outcome: Students will be able to provide RA expertise to support product development.

Requirements

This beginner-friendly course is designed to make Drug Regulatory Affairs accessible to all learners. No prior experience is required, though the following can be helpful
Curiosity and eagerness to learn about regulatory compliance, drug development, and pharmaceutical regulations.
Whether you are new to the field or seeking to advance your career, this course provides all the tools and knowledge needed to succeed in regulatory affairs.

Description

Master the fundamentals of Drug Regulatory Affairs (DRA) in a single, career-accelerating crash course.

Whether you are interested in transitioning into regulatory affairs, preparing for a role in compliance, or aiming to expand your expertise in pharmaceutical product development, this course offers a streamlined and practical introduction to the world of global drug regulation.

Designed by an industry-experienced scientist, this comprehensive program covers the entire regulatory lifecycle—from preclinical compliance and IND filing to post-marketing risk management and authority engagement. You will learn how regulatory affairs professionals ensure that pharmaceutical products meet the rigorous safety, efficacy, and quality standards required by agencies like the FDA, EMA, CDSCO, MHRA, and TGA.

Through five structured modules and 20 focused lessons, you’ll gain practical knowledge in:

Regulatory strategies for IND, NDA, ANDA, BLA, and eCTD submissions
Key global authority frameworks and jurisdictional nuances
Critical GxP standards: GMP, GLP, GCP, and ISO systems
Manufacturing, nonclinical, and clinical trial requirements
Post-marketing responsibilities, adverse event reporting, and product recalls
Authority interaction strategies, inspection readiness, and team collaboration

Each module concludes with bite-sized key takeaways and a final quiz to reinforce core principles. You will also receive curated tools like submission checklists and regulatory templates to apply your learning immediately.

Whether you are pursuing a career as a Regulatory Affairs Associate, Clinical Trial Manager, QA/QC Specialist, or simply want to understand the end-to-end drug approval process, this course delivers foundational, actionable knowledge in a compact and accessible format.

Who this course is for:

This Drug Regulatory Affairs Crash Course is designed for - Pharmacy students (B.Pharm, M.Pharm, PharmD, PhD) eager to master regulatory affairs and prepare for certification exams.
Early-career professionals in pharmaceuticals, biotech, or CROs aiming to specialize in regulatory compliance and dossier preparation.
Lifesciences graduates seeking to enter the pharmaceutical industry with practical knowledge of USFDA, EMA, GMP, and CTD/eCTD processes.
Aspiring regulatory affairs professionals looking to build expertise in drug development, pharmacovigilance, and strategic planning for career advancement.
If you are passionate about ensuring drug safety, efficacy, and compliance while boosting your pharmaceutical career, this course is your fast-track to success

Drug Regulatory Affairs: FDA, EMA, eCTD & Global Compliance

What you'll learn

Explore related topics

Course content

Module 1: Introduction to Drug Regulatory Affairs4 lectures • 28min

Module 2: Strategic Planning for Regulatory Compliance4 lectures • 35min

Module 3: Pre-Marketing Regulatory Processes4 lectures • 27min

Module 4: Post-Marketing Regulatory Responsibilities4 lectures • 27min

Module 5: Interfacing with Regulatory Authorities4 lectures • 26min

Requirements

Description

Who this course is for: